Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
Kim D, Sim NS, Woo S, Kim MH, Lee CK, Hong SS, Kim SH, Hwang HK, Kang CM, Lee WJ, Jo JH, Chung T, Hwang S, Kang B, Kim JS, Kwon CI, Kim S, Chon HJ, Kim CG, Park YN, Choi HJ.
Kim D, et al. Among authors: kim js.
Clin Mol Hepatol. 2025 Dec 26. doi: 10.3350/cmh.2025.1019. Online ahead of print.
Clin Mol Hepatol. 2025.
PMID: 41456858
Free article.